Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
A prospective study of pulmonary function in patients receiving mitomycin
Mario Castro
, Michael H. Veeder
, James A. Mailliard
, Henry D. Tazelaar
, James R. Jett
Laboratory Medicine and Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A prospective study of pulmonary function in patients receiving mitomycin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pulmonary Function
100%
Mitomycin C
100%
Pulmonary Function Test
44%
Toxic Reaction
44%
Chemotherapy
33%
Pulmonary Toxicity
22%
Worse Prognosis
11%
Solid Tumors
11%
Clinically Significant
11%
Lung Squamous Cell Carcinoma
11%
Cancer Treatment
11%
Clinical Course
11%
Cisplatin
11%
Hemoglobin
11%
Life-threatening
11%
Treatment Group
11%
North Central
11%
Underlying Disease
11%
Treatment Protocol
11%
Death Rate
11%
Corticosteroid Therapy
11%
Progression Rate
11%
Non-associated
11%
Radiological Assessment
11%
Pleural Effusion
11%
Interstitial Pneumonitis
11%
Cardiogenic Pulmonary Edema
11%
Diffusing Capacity
11%
Vinblastine
11%
Subjective Improvement
11%
Metastatic Squamous Cell Carcinoma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Study
100%
Mitomycin
100%
Chemotherapy
33%
Lung Toxicity
22%
Malignant Neoplasm
11%
Squamous Cell Carcinoma
11%
Antiinfective Agent
11%
Disease Course
11%
Solid Malignant Neoplasm
11%
Cisplatin
11%
Interstitial Pneumonia
11%
Pleura Effusion
11%
Vinblastine
11%
Radiologic Studies
11%
Noncardiogenic Lung Edema
11%
Diseases
11%
Treatment Group
11%